glp 1 approved for cardiovascular disease and mortality outcomes with GLP-1 receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia GLP-1 Medications Clinic Near Me

Eric Steidley, Lisa LeMond, Robert Scott, Kristen Sell-Dottin, Parag Patel, MD, Alfredo Clavell To view or add a comment, sign in 425 followers

This study provides insight into how differential dynamics of peptideligand engagement with the GLP-1R TMD can promote differences in G protein-mediated signalling, improving molecular understanding of mechanisms that contribute to ligand-dependent differential efficacy at the GLP-1R

Research into blood safety and storage

The risks fall into three buckets Common, mild, self-limiting Bruising or soreness at the catheter site Cool sensation along the arm during the drip Warm flush or metallic taste, especially with magnesium or B-complex Mild lightheadedness if the drip runs too fast Uncommon Phlebitis, or vein irritation, especially with stronger or more concentrated formulas Infiltration (fluid leaking under the skin if the catheter shifts) Allergic reactions to specific ingredients, particularly thiamine and B-complex Rare but serious Infection at the IV site Fluid overload in patients with heart, kidney, or liver disease Electrolyte disturbances, especially with high-dose magnesium, potassium, or calcium Red blood cell problems in people with G6PD deficiency, a genetic enzyme issue

the procedure is performed comfortably while you're awake